Affordable Access

deepdyve-link
Publisher Website

Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.

Authors
  • Jean, Shio-Shin1
  • Hsieh, Tai-Chin2
  • Hsu, Chin-Wan3
  • Lee, Wen-Sen2
  • Bai, Kuan-Jen3
  • Lam, Carlos3
  • 1 Emergency Medicine, Department of Emergency and Critical Care Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: [email protected] , (Taiwan)
  • 2 Division of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. , (Taiwan)
  • 3 Emergency Medicine, Department of Emergency and Critical Care Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. , (Taiwan)
Type
Published Article
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Publication Date
Dec 01, 2016
Volume
49
Issue
6
Pages
924–933
Identifiers
DOI: 10.1016/j.jmii.2015.06.009
PMID: 26341302
Source
Medline
Keywords
License
Unknown

Abstract

Although the TIC regimen showed good efficacy, its value regarding managing XDR-Ab ventilator-associated pneumonia bacteremia needs further evaluation.

Report this publication

Statistics

Seen <100 times